Status:
COMPLETED
Evaluation of Benztropine for Cocaine Craving - 2
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
Washington D.C. Veterans Affairs Medical Center
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
22-48 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare the efficacy of benztropine (or DA reuptake inhibitor) with atropine and placebo in affecting stimulated craving to cocaine cues.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
End Date :
April 1 2003
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000333
Start Date
May 1 2001
End Date
April 1 2003
Last Update
February 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington DC VA
Washington D.C., District of Columbia, United States, 20422